Evidence map›Paper›PMID 35755227›Full record

ArticleThe Neurohospitalist2022

Cross-Sectional Retrospective Study to Identify Clinical and Radiographic Features Associated With VZV Reactivation in Cryptogenic Stroke Patients With CSF Testing.

Ekaterina Bakradze, Charles C Esenwa, D Scott Schmid, Kathryn F Kirchoff-Torres, Daniel Antoniello, Peter C Mabie, Daniel L Labovitz, Congrong Miao, Ava L Liberman

Open access · greenAbstract read
In one paragraph

Article in The Neurohospitalist, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ekaterina BakradzeDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID https://orcid.org/0000-0001-7534-7218
Charles C EsenwaDepartment of Neurology, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
D Scott SchmidDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Kathryn F Kirchoff-TorresDepartment of Neurology, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Daniel AntonielloDepartment of Neurology, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.ORCID https://orcid.org/0000-0002-4680-7948
Peter C MabieDepartment of Neurology, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Daniel L LabovitzDepartment of Neurology, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Congrong MiaoDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Ava L LibermanSaul R. Korey Department of Neurology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Jacobi Medical Center · USUniversity of Alabama at Birmingham · USAlbert Einstein College of Medicine · US

Funding

The Misdiagnosis of Cerebrovascular Disease in Emergent Headache EvaluationsK23NS107643 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI LIBERMAN, AVA L · 2018 to 2022
$997k
NINDS NIH HHS K23 NS107643
6 · The paper itself

Abstract

Background and Purpose: A large proportion of ischemic stroke patients lack a definitive stroke etiology despite extensive diagnostic testing. Varicella-Zoster Virus (VZV) can directly invade blood vessels causing vasculitis and may be associated with cryptogenic stroke (CS). Methods: We conducted a retrospective cross-sectional study of CS patients tested for VZV. The following were considered evidence of VZV reactivation (VZV+): positive CSF VZV PCR, anti-VZV IgM in CSF, or anti-VZV IgG CSF/serum ratio of 1:10 or higher. We describe the cohort, report VZV+ proportion with 95% confidence intervals (CI) determined with the Wald method, and compare patient groups using standard statistical tests. Results: A total of 72 CS patients met full study inclusion criteria. Most of the patients were <65 years old, had few traditional vascular risk factors, and had multifocal infarcts. Mean age was 49 years (SD ±13) and 47% were women. A total of 14 patients (19.4%; CI: 11.4-30.8%) had evidence of CNS VZV reactivation. There was no difference in evaluated demographic or radiographic features between those with versus without evidence of VZV reactivation. History of ischemic stroke in the past year (11/14 vs 25/43, Conclusion: We found a high proportion of CNS VZV reactivation in a cross-sectional cohort of CS patients selected for CSF testing. Testing for VZV might be reasonable in CS patients who are young, have multifocal infarcts, or had an ischemic stroke within the past year, but additional research is needed.

Indexed as

cryptogenic strokeischemic strokevaricella zoster virusvasculitis

Identifiers

PMID35755227
PMCPMC9214924
OpenAlexW4214523979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.